Could statins be useful in the treatment of patients with migraine?

被引:30
作者
Liberopoulos, EN [1 ]
Mikhailidis, DR [1 ]
机构
[1] Royal Free Hosp, Sch Med, Dept Clin Biochem, London NW3 2QG, England
来源
HEADACHE | 2006年 / 46卷 / 04期
关键词
cholesterol; headache; migraine; statins; vascular; stroke;
D O I
10.1111/j.1526-4610.2006.00293.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Migraine is a common and disabling neurological disorder. Studies have shown that patients with migraine (especially those with typical aura with migraine) have an unfavorable cardiovascular risk profile and an increased risk of early-onset (< 45 years) ischemic stroke. Statins are effective hypolipidemic drugs that reduce cardiovascularrelated morbidity and death in patients with or without established atherosclerotic vascular disease. We report a patient whose frequent attacks of typical aura with migraine completely resolved after the initiation of treatment with a statin. In this context, we comment on the possible effects of statins on the pathophysiology of migraine. We suggest that statins may be useful drugs in the treatment of migraine because they could reduce the increased cardiovascular risk in these patients and also attenuate migraine attacks. Only a randomized prospective study in this population could provide a definite answer to these speculations.
引用
收藏
页码:672 / 675
页数:4
相关论文
共 36 条
[1]  
[Anonymous], [No title captured]
[2]   Comparative efficacy and safety of ciprofibrate and sustained-release bezafibrate in patients with type II hyperlipidaemia [J].
Betteridge, DJ ;
OBryanTear, CG .
POSTGRADUATE MEDICAL JOURNAL, 1996, 72 (854) :739-743
[4]  
Chang CL, 1999, BMJ-BRIT MED J, V318, P13
[5]   STATT: A titrate-to-goal study of simvastatin in Asian patients with coronary heart disease [J].
Chung, N ;
Cho, SY ;
Choi, DH ;
Zhu, JR ;
Lee, K ;
Lee, PY ;
Lee, SH ;
Lee, S ;
Wang, JJ ;
Yin, WH ;
Young, MS ;
Koh, KK ;
Son, JW ;
Sangwatanaroj, S ;
Panchavinnin, P ;
Phankingthongkum, R ;
Cai, NS ;
Fan, WF .
CLINICAL THERAPEUTICS, 2001, 23 (06) :858-870
[6]   Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects [J].
Cilla, DD ;
Whitfield, LR ;
Gibson, DM ;
Sedman, AJ ;
Posvar, EL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (06) :687-695
[7]   PLATELET AGGREGABILITY IN MIGRAINE [J].
COUCH, JR ;
HASSANEIN, RS .
NEUROLOGY, 1977, 27 (09) :843-848
[8]   Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies [J].
Etminan, M ;
Takkouche, B ;
Isorna, FC ;
Samii, A .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7482) :63-65
[9]   Emerging therapies for cerebrovascular disorders [J].
Fisher, M ;
Davalos, A .
STROKE, 2004, 35 (02) :367-369
[10]   Local inflammation as a mediator of migraine and tension-type headache [J].
Friedman, MH .
HEADACHE, 2004, 44 (08) :767-771